Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Platelet gene expression and function in patients with COVID-19
2020 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Evaluation of Serum Procalcitonin in Patients with Systemic Inflammatory Response Syndrome with and without Infection
2009
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Platelet function in HIV plus dengue coinfection associates with reduced inflammation and milder dengue illness
2019
Allogeneic Hematopoietic Cell Transplantation in Human Immunodeficiency Virus–Positive Patients with Hematologic Disorders: A Report from the Center for International Blood and Marrow Transplant Research
2009
Persistent immune activation in chronic HIV infection
2013
Sepsis biomarkers: a review
2010 Standout
Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model
2018
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Clinical and Biological Evolution of HIV-1 Seroconverters in Abidjan, Côte d'Ivoire, 1997–2000
2002 StandoutNobel
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
2008 Standout
PREVALENCE OF VIABLE TOXOPLASMA GONDII IN BEEF, CHICKEN, AND PORK FROM RETAIL MEAT STORES IN THE UNITED STATES: RISK ASSESSMENT TO CONSUMERS
2005
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
A Randomized, Placebo‐Controlled Study of Rifabutin Added to a Regimen of Clarithromycin and Ethambutol for Treatment of Disseminated Infection with Mycobacterium avium Complex
1999
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
2013 Standout
CD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut
2010
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
2017 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome
2003
Role of C-Reactive Protein at Sites of Inflammation and Infection
2018 Standout
Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS
2015
Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort
2010
Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22
2011
Life expectancy living with HIV
2012
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
2008
Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons
2006
Highly active antiretroviral therapy (Haart) for the treatment of infection with human immunodeficiency virus type 1
1999
Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit
2005
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART)
2008
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals
2008
Serum MicroRNAs in HIV-Infected Individuals as Pre-Diagnosis Biomarkers for AIDS-NHL
2014
Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials
2008
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study
2007
C-reactive protein as a marker of infection in critically ill patients
2005
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV
2010
d-dimer is a significant prognostic factor in patients with suspected infection and sepsis
2012
Identification of NV‐F virus DNA in hepatocellular carcinoma
2006
Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals
2018
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
2011
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Prospective Randomized Trial of Four Three‐Drug Regimens in the Treatment of DisseminatedMycobacterium aviumComplex Disease in AIDS Patients: Excess Mortality Associated with High‐Dose Clarithromycin
1999
Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment
2009
MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003
2005
Epidemiology of Lung Cancer
2013
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection
2000
Pulmonary Toxoplasmosis in Patients Infected with Human Immunodeficiency Virus: A French National Survey
1996
HIV Infection Is Associated with an Increased Risk for Lung Cancer, Independent of Smoking
2007
Uncontrolled Viral Replication as a Risk Factor for Non-AIDS Severe Clinical Events in HIV-Infected Patients on Long-Term Antiretroviral Therapy: APROCO/COPILOTE (ANRS CO8) Cohort Study
2009
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
2008
Discrimination against HIV-Infected People and the Spread of HIV: Some Evidence from France
2007
Global burden of liver disease: 2023 update
2023 Standout
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis
2007
Epidemiology of Cryptococcal Meningitis in the US: 1997–2009
2013
Functional Specialization of Interleukin-17 Family Members
2011 Standout
Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward
2008 Standout
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Innate lymphoid cells — a proposal for uniform nomenclature
2013 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission—a randomized trial
2009
Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe
2010
Global challenges in liver disease
2006
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Discriminative Value of Inflammatory Biomarkers for Suspected Sepsis
2011
Platelets in Immune Response to Virus and Immunopathology of Viral Infections
2018
Natural history of hepatitis C
2014
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Replication of hepatitis C virus
2007 StandoutNobel
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases
2016
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus
2006
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies
2008
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-up
2008
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein
2004
The impact of HIV on hepatocellular cancer survival in Nigeria
2020
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Echinococcosis: Advances in the 21st Century
2019 Standout
Toward Resolving the Challenges of Sepsis Diagnosis
2004
Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START ) trial
2015
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Splicing Diversity of the Human OCLN Gene and Its Biological Significance for Hepatitis C Virus Entry
2010 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
2007
Works of Thierry May being referenced
Causes of Death in HIV-Infected Individuals with Immunovirologic Success in a National Prospective Survey
2016
Comparison of Combination Therapy Regimens for Treatment of Human Immunodeficiency Virus–Infected Patients with Disseminated Bacteremia Due toMycobacterium avium
1997
Causes of death among HIV-infected patients in France in 2010 (national survey)
2014
Changes in Cancer Mortality among HIV‐Infected Patients: The Mortalité 2005 Survey
2009
Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol
2005
Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral-experienced patients
1998
Malignancy‐related causes of death in human immunodeficiency virus–infected patients in the era of highly active antiretroviral therapy
2004
Low Serum Procalcitonin Level Accurately Predicts the Absence of Bacteremia in Adult Patients with Acute Fever
2002
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study
2009
Extracerebral Toxoplasmosis in Patients Infected with HIV A French National Survey
1994
Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic)
2008
Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France
2005
Primary Cerebral Alveolar Echinococcosis: Mycology to the Rescue
2013
[Causes of death in HIV-infected French drug users, 1995-2000].
2002